[Cerebellar infarction following remission induction therapy in acute lymphoblastic leukemia].
D015250:Aclarubicin; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage; D002531:Cerebellum / Q000098:blood supply*; D002544:Cerebral Infarction / Q000209:etiology*; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D009279:Naphthacenes / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D012074:Remission Induction; D014750:Vincristine / Q000008:administration & dosage
D009279:Naphthacenes; D014750:Vincristine; D015250:Aclarubicin; D011239:Prednisolone; D001215:Asparaginase